Crimson Publishers Publish With Us Reprints e-Books Video articles


Modern Applications in Pharmacy & Pharmacology

A Brief Review of Antifungal Drugs Old and New

  • Open or Close Richard W Dudley*

    Department of Pharmaceutical Sciences, The University of Findlay, USA

    *Corresponding author: Richard W Dudley, Department of Pharmaceutical Sciences, The University of Findlay, Findlay, OH 45840, USA

Submission: April 03, 2018; Published: May 23, 2018

DOI: 10.31031/MAPP.2018.02.000530

ISSN 2637-7756
Volume2 Issue1


Advances in chemotherapy, immunotherapy, and the treatment of HIV have had a tremendous positive impact on survival and have decreased disease-related morbidity. However, such therapies have increased the number of patients with a compromised immune system thereby predisposing to opportunistic fungal infections. Despite currently available antifungal drugs, mortality rates remain elevated. Drug approvals for cancer, HIV, and transplantation continue and have significantly outpaced antifungal drug therapy development. Here, a brief review of current therapies is presented as well as investigational antifungal agents with novel mechanisms of action or molecular targets.

Keywords: Anti fungal; Opportunistic infections; Candida spp; Echinocandins; Azole antifungal

Get access to the full text of this article